Back to search

National and Kapodistrian University of Athens

Η επίδραση της εφαρμογής θεραπείας με συνεχή θετική πίεση αεραγωγών επί του επικαρδιακού λιπώδους ιστού και παραγόντων καρδιομεταβολικού κινδύνου, σε πρωτοδιαγνωσμένους ασθενείς με σύνδρομο αποφρακτικής άπνοιας στον ύπνο

Abstract

dc:description

Abstract AimThe aim of this study was to assess an independent relationship between obstructive sleep apnea - hypopnea syndrome (OSAHS) sever¬ity, metabolic and vascular markers, and epicardial fat, at base¬line and after 3 months of continuous positive airway pressure (CPAP) therapy.Materials and method Our study group consisted of 48 pa¬tients with suspected OSAHS and no prior history of cardio¬vascular disease or diabetes mellitus. All patients underwent full overnight polysomnography. Thickness of epicardial and visceral adipose tissue, brachial artery flow-mediated dilation (FMD), carotid intima media thickness (cIMT), pulse wave velocity (PWV), HbA1c, homeostatic model assessment of insulin resistance index (HOMA - IR), and lipid profile were measured at baseline and after 3 months of CPAP use in pa¬tients with moderate to severe OSAHS.Results In OSAHS patients (Apnea-hypopnea index (AHI) >15/h, N=28), epicardial fat correlated with fasting glucose (rho=0.406, p=0.04) and HOMA - IR (rho=0.525, p=0.049) but was not associated with visceral fat (rho=0.126, p=0.595). Epicardial adipose tissue (EAT) (p=0.022) increased across AHI severity along with PWV (p=0.045) and carotid intima media thickness (cIMT) (p=0.034) while FMD (p=0.017) de¬creased. Therapy with CPAP reduced both epicardial (p<0.001) and visceral fat (p=0.001). Alterations in epicardial fat across the follow-up were associated with changes in PWV (p=0.026) and HOMA - IR (p=0.037) independently of major confounders.Conclusions Epicardial fat thickness was associated with OSAHS severity and may be an additional marker of cardiovas¬cular risk as well as of future diabetes in these patients. CPAP therapy reduced epicardial fat, suggesting its potentially beneficial role in reducing cardiometabolic risk in OSAHS patients.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • kostopoulos, kostas
  • Κωστόπουλος, Κωνσταντίνος

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36295

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

kostopoulos, kostas; Κωστόπουλος, Κωνσταντίνος. Η επίδραση της εφαρμογής θεραπείας με συνεχή θετική πίεση αεραγωγών επί του επικαρδιακού λιπώδους ιστού και παραγόντων καρδιομεταβολικού κινδύνου, σε πρωτοδιαγνωσμένους ασθενείς με σύνδρομο αποφρακτικής άπνοιας στον ύπνο. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/36295